DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Patt YZ et al.
Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.
J Clin Oncol 2003;
21 (03) 421-427
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.